Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

[No abstract available]

키워드

AmfebutamoneAmine Oxidase (flavin Containing)C Reactive ProteinInsulinNaltrexoneAmfebutamone Plus NaltrexoneAmfebutamoneAmine Oxidase (flavin Containing)C Reactive ProteinHigh Density Lipoprotein CholesterolInsulinLow Density Lipoprotein CholesterolMonoamineNaltrexoneTriacylglycerolAmfebutamone Plus NaltrexoneBlood PressureCardiovascular RiskClinical Trial (topic)Heart RateHumanLetterLipid Blood LevelMedical PracticeMental DiseaseObesityPhase 3 Clinical Trial (topic)Quality Of LifeWaist CircumferenceDrug TherapyNoteTHERAPYWEIGHT
제목
Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]
저자
Lyu, Young SangAhn, HongyupHong, SangmoPark, Cheol-Young
DOI
10.2147/DDDT.S512114
발행일
2025
유형
Letter
저널명
Drug Design, Development and Therapy
19
페이지
65 ~ 66